LL-37 peptide claims on TikTok: what the research actually says

What did @coachcam.peps3 actually say?

The creator describes LL-37 as "the only human cathelicidin in the entire human body" and walks through its antimicrobial mechanism, calling it a kind of membrane-collapsing agent using a Golden Gate Bridge analogy. They claim it kills bacteria, viruses, and fungi by disrupting membranes, neutralizes bacterial debris like lipopolysaccharides (LPS), breaks up antibiotic-resistant biofilms, recruits immune cells, supports gut barrier function, and promotes wound healing through angiogenesis. The video closes with a claim that vitamin D levels directly govern how much LL-37 your body can produce, implying that subclinical vitamin D deficiency could explain chronic illness.

To their credit, they add a disclaimer that this is for "educational research purposes only" and not medical advice. They are not selling LL-37 directly in this video, though they do reference a paid "school" for deeper content.

Does the science back this up?

Mostly yes, with important caveats. LL-37 is a genuinely well-studied antimicrobial peptide, and the core claims here are supported by peer-reviewed literature. But the framing skews heavily toward benefit while skipping the documented risks.

The cathelicidin claim is accurate. Humans have one cathelicidin gene, CAMP, which produces the precursor hCAP18, processed into the active peptide LL-37 (Vandamme et al., 2012, Cellular and Molecular Life Sciences). The membrane disruption mechanism, including the carpet model the creator mentions, is well-documented (Shai, 2002, Biopolymers). LPS neutralization by LL-37 has been shown in vitro and in animal models (Scott et al., 2002, Journal of Immunology). Biofilm disruption activity has solid evidence behind it (Dean et al., 2011, Journal of Innate Immunity). The vitamin D-LL-37 connection is real: vitamin D induces CAMP gene expression, and this has been demonstrated in human cells (Liu et al., 2006, Science).

What's missing is context on LL-37's dark side. Elevated LL-37 is associated with psoriasis, lupus, and certain cancers. This peptide is not a simple immune booster with no downsides.

What did they get wrong (or right)?

The creator gets the foundational biology right. LL-37 really is the only human cathelicidin. The carpet model is a legitimate mechanistic description. The LPS neutralization point is backed by evidence. Vitamin D's role in regulating LL-37 production is one of the better-supported claims in this space.

Where things get slippery: the creator implies LL-37 supplementation is a logical solution to these problems, saying things like "if you're pairing LL-37 or something like BPC you can actually get some very good substantial gut repair." That is not established in human clinical trials. Most LL-37 research is in vitro or animal-based. Suggesting that exogenous LL-37 administered as a peptide supplement will replicate the endogenous immune functions described here is a significant leap. The bioavailability and stability of injected LL-37 in humans is not well characterized in clinical literature.

The video also describes LL-37 as capable of killing viruses and fungi. The antiviral and antifungal evidence exists but is considerably thinner than the antibacterial data, and mostly comes from cell culture studies (Bergman et al., 2007, Current Pharmaceutical Design).

What should you actually know?

LL-37 is a legitimate area of immunology research, but the gap between "this molecule does interesting things in a lab" and "you should take this as a peptide" is enormous, and this video does not fully bridge it honestly.

Exogenous LL-37 as a therapeutic is still largely experimental. There are no FDA-approved LL-37 peptide therapies as of 2024. Some topical formulations are in clinical trials for wound care (e.g., Lipigon Pharmaceuticals' work), but systemic injectable use in humans lacks robust safety or efficacy data. The creator's framing of LL-37 as something you can pair with BPC-157 for gut repair combines two compounds neither of which has strong human RCT data for that application.

The vitamin D point is arguably the most actionable and evidence-supported takeaway in the whole video. If you are chronically ill and have not checked your 25-OH vitamin D level, that is a reasonable starting point with your actual doctor. That said, optimizing vitamin D to support endogenous LL-37 production is a very different proposition from injecting synthetic LL-37.

• Do not interpret this video as evidence that LL-37 peptide injections are safe or effective in humans for any of the conditions described.
• The biology described is real. The therapeutic leap is not yet supported by clinical trial data.
• Elevated LL-37 is linked to autoimmune and inflammatory conditions. More is not automatically better.